Safety and efficacy of venetoclax-azacitidine combined with low-dose Idarubicin and cytarabine regimens for the treatment of newly diagnosed acute myeloid leukemia patients compared to the standard chemotherapy: a propensity score-matched real-world single-center experience

Related articles

1. CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients

   This article has 30 authors:

   1. Naseema Gangat
   2. Saubia Fathima
   3. Lior Rokach
   4. Nour Ghosoun
   5. Mahsa Rezasoltani
   6. Rimal Ilyas
   7. Ali Alsugair
   8. Kristen McCullough
   9. Maymona Abdelmagid
   10. Aref Al-Kali
   11. Hassan Alkhateeb
   12. Kebede Begna
   13. Abhishek Mangaonkar
   14. Aasiya Matin
   15. Antoine Saliba
   16. Mehrdad Hefazi
   17. Mark R. LITZOW
   18. William Hogan
   19. Mithun Shah
   20. Mrinal Patnaik
   21. Animesh Pardanani
   22. Talha Badar
   23. Hemant Murthy
   24. James Foran
   25. Jeanne Palmer
   26. Nathan Punwani
   27. Lisa Sproat
   28. Nandita Khera
   29. Cecilia Arana Yi
   30. Ayalew Tefferi

2. Real-life Multicenter Experience of Long-term Treatment With Venetoclax Plus Azacitidine for Acute Myeloid Leukemia in China

   This article has 10 authors:

   1. Xuexing Chen
   2. Qiong Yan
   3. Chunfang Li
   4. Fei Liu
   5. Shaojun Guo
   6. juan Zhao
   7. Yan Liang
   8. Haiyan Wang
   9. weiming Li
   10. Guolin Yuan

3. Adult Patients with Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Multiagent Chemotherapy Regimen, in Combination with a TKI, Do Not Require Routine alloSCT

   This article has 16 authors:

   1. Donna Zhe Sian Eng
   2. Fatime Khadadah
   3. Maria Agustina Perusini
   4. Eshrak Al Shaibani
   5. Eshetu G. Atenafu
   6. Aniket Bankar
   7. Marta Davidson
   8. Guillaume Richard-Carpentier
   9. Dawn Maze
   10. Karen Yee
   11. Aaron Schimmer
   12. Vikas Gupta
   13. Steven Chan
   14. Dennis Dong Hwan Kim
   15. Andre Schuh
   16. Hassan Sibai